Press release from Companies: The subscription price for the warrants of series TO3 in PEPTONIC medical AB has been determined to SEK 0.05 and the exercise period starts November 2, 2023

Press release from Companies: Teckningskursen för teckningsoptioner av serie TO3 i PEPTONIC medical AB har fastställts till 0,05 SEK och nyttjandeperioden inleds den 2 november 2023

Press release from Companies: Peptonics VD Erik Sundquist intervjuas av Finwire.tv

Press release from Companies: Peptonic to present at BioStock Life Science Fall Summit on October 26

Press release from Companies: Peptonic presenterar på BioStock Life Science Fall Summit den 26 oktober

Press release from Companies: Peptonic presenterar på BioStock Life Science Fall Summit den 26 oktober

Reports: PEPTONIC Medical AB (publ), QUARTERLY REPORT Period January – September 2023

Reports: PEPTONIC Medical AB (publ), QUARTERLY REPORT Period January – September 2023

Reports: PEPTONIC Medical AB (publ), Delårsrapport Perioden januari – september 2023

Press release from Companies: Peptonic receives first order from Windsor Pharmaceuticals in Central America

Press release from Companies: Peptonic får första order från Windsor Pharmaceuticals i Centralamerika

Press release from Companies: Peptonic offentliggör preliminär tidplan avseende fusionen med Pharmiva